These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28106707)

  • 21. [Clinical risk factors for proliferative vitreoretinopathy after retinal detachment surgery].
    Lleó Pérez A ; Campos Fernández R ; López Santoveña F ; Sánchez Lorente G ; Hernández Martínez FJ ; Navarro Palop C
    Arch Soc Esp Oftalmol; 2000 Nov; 75(11):741-750. PubMed ID: 11151263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Proliferative vitreoretinopathy in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
    Kunavisarut P; Bijlsma WR; Pathanapitoon K; Patikulsila D; Choovuthayakorn J; Rothova A
    Am J Ophthalmol; 2010 Aug; 150(2):218-22. PubMed ID: 20525529
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Introduction of the MDM2 T309G Mutation in Primary Human Retinal Epithelial Cells Enhances Experimental Proliferative Vitreoretinopathy.
    Zhou G; Duan Y; Ma G; Wu W; Hu Z; Chen N; Chee Y; Cui J; Samad A; Matsubara JA; Mukai S; D'Amore PA; Lei H
    Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5361-5367. PubMed ID: 29049737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative vitreoretinopathy: cytologic findings in vitreous samples.
    Martín F; Pastor JC; De La Rúa ER; Mayo-Iscar A; García-Arumí J; Martínez V; Fernández N; Saornil MA
    Ophthalmic Res; 2003; 35(4):232-8. PubMed ID: 12815199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokines in proliferative vitreoretinopathy.
    Limb GA; Little BC; Meager A; Ogilvie JA; Wolstencroft RA; Franks WA; Chignell AH; Dumonde DC
    Eye (Lond); 1991; 5 ( Pt 6)():686-93. PubMed ID: 1800167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elucidation of the pathogenic mechanism of rhegmatogenous retinal detachment with proliferative vitreoretinopathy by proteomic analysis.
    Yu J; Peng R; Chen H; Cui C; Ba J
    Invest Ophthalmol Vis Sci; 2012 Dec; 53(13):8146-53. PubMed ID: 23139279
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of thrombin in proliferative vitreoretinopathy.
    Bastiaans J; van Meurs JC; Mulder VC; Nagtzaam NM; Smits-te Nijenhuis M; Dufour-van den Goorbergh DC; van Hagen PM; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(7):4659-66. PubMed ID: 25015355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Potential to predict the risk of developing proliferative vitreoretinopathy with the analysis of clinical factors of regmatogenous retinal detachments].
    Rodríguez de la Rúz Franch E; Aragón Roca JA; Pastor Jimeno JC; Carrasco Herrero B; González Rodríguez JC; Alvarez Requejo A; Martín De Diego I; Giraldo Arguello A
    Arch Soc Esp Oftalmol; 2000 Dec; 75(12):807-12. PubMed ID: 11151277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Postoperative proliferative vitreoretinopathy in rhegmatogenous retinal detachment associated with stage B preoperative proliferative vitreoretinopathy: comparative results of trans-scleral retinopexy with diode laser or trans-pupillary retinopexy with argon laser].
    Duquesne N; Fleury J; Bonnet M
    J Fr Ophtalmol; 1998 Oct; 21(8):555-9. PubMed ID: 9833220
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of lymphotoxin-alpha gene polymorphisms (rs909253, rs1800683 and rs2229094) and risk of large-artery atherosclerosis stroke in Iranian population.
    Fasihi A; Pourhamedi S; Zahedi M; Goudarzian M; Ramazi S; Kafashzadeh M; Heydari-Zarnagh H
    J Gene Med; 2020 Oct; 22(10):e3229. PubMed ID: 32415894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional characterization of rs2229094 (T>C) polymorphism in the tumor necrosis factor locus and lymphotoxin alpha expression in human retina: the Retina 4 project.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Gonzalez-Buendia L; Delgado-Tirado S; López JC; González-Sarmiento R; Pastor JC
    Clin Ophthalmol; 2017; 11():973-981. PubMed ID: 28579748
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An endoscopic overview of the anterior vitreous base in retinal detachment and anterior proliferative vitreoretinopathy.
    Boscher C; Kuhn F
    Acta Ophthalmol; 2014 Jun; 92(4):e298-304. PubMed ID: 24428936
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MIF promoter polymorphisms are associated with epiretinal membrane but not retinal detachment with PVR in an american population.
    Cebulla CM; Stevenson W; Van Law H; Heisler-Taylor T; Hamadmad S; Shah MH; Kim B; Davidorf FH; Ohr M; Wells M; Yanoga F; Chang S; Terrell W; Miller DM; Klisovic D; Allen JB; Shah N; Geraymovych E; Tarabishy AB; Kondapalli SS; Brewington BY; Inman A; Williams D; Kusibati R; Mathias J; Vedat Y; Fernandez S; Wisely CE; Pilarski R; Abdel-Rahman MH
    Exp Eye Res; 2019 Aug; 185():107667. PubMed ID: 31108057
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
    Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
    Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel function of p53: a gatekeeper of retinal detachment.
    Lei H; Rheaume MA; Cui J; Mukai S; Maberley D; Samad A; Matsubara J; Kazlauskas A
    Am J Pathol; 2012 Sep; 181(3):866-74. PubMed ID: 22901751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between a polymorphism in the lymphotoxin-a promoter region and migraine.
    Lee KA; Jang SY; Sohn KM; Won HH; Kim MJ; Kim JW; Chung CS
    Headache; 2007; 47(7):1056-62. PubMed ID: 17635597
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pars plana vitrectomy and scleral buckle versus pars plana vitrectomy alone for patients with rhegmatogenous retinal detachment at high risk for proliferative vitreoretinopathy.
    Storey P; Alshareef R; Khuthaila M; London N; Leiby B; DeCroos C; Kaiser R;
    Retina; 2014 Oct; 34(10):1945-51. PubMed ID: 24999720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characteristics of rhegmatogenous retinal detachment and their relationship to success rates of surgery.
    Williamson TH; Lee EJ; Shunmugam M
    Retina; 2014 Jul; 34(7):1421-7. PubMed ID: 24480842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Proliferative vitreoretinopathy: pathophysiology and clinical diagnosis].
    Rouberol F; Chiquet C
    J Fr Ophtalmol; 2014 Sep; 37(7):557-65. PubMed ID: 24997864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors, anatomical, and visual outcomes of injured eyes with proliferative vitreoretinopathy: eye injury vitrectomy study.
    Feng K; Hu Y; Wang C; Shen L; Pang X; Jiang Y; Nie H; Wang Z; Ma Z
    Retina; 2013 Sep; 33(8):1512-8. PubMed ID: 23538583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.